| Amount | Holding |
|---|---|
| 3.94% | Sarepta Therapeutics, Inc |
| 3.90% | Exelixis, Inc |
| 3.86% | Neurocrine Biosciences, Inc |
| 3.80% | Charles River Laboratories International, Inc |
| 3.79% | Bio-Techne Corporation |
| 3.66% | BioMarin Pharmaceutical Inc |
| 3.58% | Ultragenyx Pharmaceutical Inc |
| 3.55% | Alexion Pharmaceuticals, Inc |
| 3.53% | Exact Sciences Corporation |
| 3.52% | Seattle Genetics, Inc |